Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article belongs to the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx holds no commercial relationship with Hers or its parent company, and there are no affiliate links or paid placements anywhere in this article.

Type "Hers Ozempic" into a search bar and the results tend to conflate two different things: Ozempic, a specific branded medicine, and the semaglutide a telehealth program might actually dispense. This editorial piece separates the two, walks through how Hers routes a prescription, and flags the genetic layer that sits underneath any of it. Fair-balance framing, not a purchase recommendation. As of April 2026.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

What "Ozempic through Hers" really refers to

Ozempic is a brand name for semaglutide, an injectable GLP-1 receptor agonist that the FDA approved for type 2 diabetes and that is widely discussed for its metabolic effects. A telehealth weight program does not hand out a diabetes brand casually; when people picture "Ozempic through Hers," they are usually picturing semaglutide reached through a prescription pathway, which may mean an FDA-approved branded product from a retail pharmacy or a compounded semaglutide preparation from a 503A pharmacy. The distinction matters because the two routes are dispensed differently.

How the telehealth prescription pathway works

Hers, part of Hims & Hers Health, runs on a subscription telehealth structure. A prospective patient completes an intake covering weight, medical history, and current medications; a licensed clinician reviews that file and, where clinically appropriate, writes a prescription; the order is then routed to either a retail pharmacy for a branded product or a licensed compounding pharmacy for a compounded one; and follow-up visits support titration and side-effect management. Whether you interact with a physician or an NP or PA, and which pharmacy fills the order, varies by case. Confirm the current structure directly at Hers's official website.

Branded versus compounded semaglutide

The compound underneath both routes is the same molecule, but the supply chain is not. Branded semaglutide is a finished FDA-approved product; compounded semaglutide is prepared by a 503A pharmacy and is not an FDA-approved product in its own right. Cost, availability, and how a program describes the medicine all shift depending on which route applies. Published costs for any Hers plan live on the brand's own site, and across the telehealth GLP-1 market monthly totals as of April 2026 generally land somewhere between roughly $200 and $700+, with wide variance by product and tier.

What the semaglutide trial record shows

The pharmacology here rests on the GLP-1 receptor agonist class, which also includes liraglutide and dulaglutide, alongside the GIP/GLP-1 dual agonist tirzepatide. The STEP program studied semaglutide for weight management (The New England Journal of Medicine, 2021), while SURMOUNT (NEJM, 2022) and SURMOUNT-OSA (NEJM, 2024) examined tirzepatide for weight and for obstructive sleep apnea. Trial populations and endpoints differ, and individual outcomes vary.

The genetic layer these programs leave out

Ozempic-focused programs does not account for the upstream genetic architecture that shapes how any GLP-1 compound behaves in a given body. Variants in FTO, the fat-mass and obesity-associated gene, along with GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the metabolic terrain a clinician is prescribing into. These are pathway-level signals. They do not predict response to any specific medication, but they map the biology beneath the decision, context a telehealth prescription on its own never captures.

PlexusDx provides semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is that upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, GLP1R, MC4R, and TCF7L2 variants that shape baseline appetite-regulation and energy-balance biology. Pairing that profile with the protocol is the test before you invest approach, turning guesswork into an informed conversation with your healthcare provider.

Not affiliated: PlexusDx is not affiliated with Hers and holds no commercial relationship with the companies discussed in this article.

Related reading on PlexusDx: Ozempic Cost At Walmart, Ozempic For PCOS, Cheap Ozempic, Ozempic Price Without Insurance.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: explore the Weight Management Protocols for semaglutide and tirzepatide paired with the genetic context most telehealth programs omit. Or begin upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

Does Hers prescribe actual Ozempic?

Ozempic is a branded semaglutide product. A telehealth program may dispense an FDA-approved branded semaglutide or a compounded semaglutide preparation from a 503A pharmacy, depending on eligibility and route. Check the brand's own site to confirm exactly which product any specific plan provides before you commit.

Is compounded semaglutide the same as Ozempic?

They share the semaglutide molecule, but a branded product is FDA-approved while a compounded preparation made by a 503A pharmacy is not an FDA-approved product. The supply chain, availability, and labeling differ, so the two are not regulatory equivalents even when the active ingredient matches.

How does the Precision Peptide Genetic Test relate to semaglutide?

It does not predict how you will respond to semaglutide or any branded drug. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe baseline GLP-1 biology, providing upstream context that applies regardless of which program or product a clinician ultimately prescribes.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves